{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:02:17Z","timestamp":1788282137185,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00792"],"award-info":[{"award-number":["PI19\/00792"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00584"],"award-info":[{"award-number":["PI22\/00584"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00473"],"award-info":[{"award-number":["PI22\/00473"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS23\/00037"],"award-info":[{"award-number":["DTS23\/00037"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIPF-2022\/SAL-GL-24790"],"award-info":[{"award-number":["PIPF-2022\/SAL-GL-24790"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"\u201cConvocatoria predoctoral Consejer\u00eda de Educaci\u00f3n, ciencia y Universidades de la Comunidad de Madrid\u201d","doi-asserted-by":"publisher","award":["PI19\/00792"],"award-info":[{"award-number":["PI19\/00792"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"\u201cConvocatoria predoctoral Consejer\u00eda de Educaci\u00f3n, ciencia y Universidades de la Comunidad de Madrid\u201d","doi-asserted-by":"publisher","award":["PI22\/00584"],"award-info":[{"award-number":["PI22\/00584"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"\u201cConvocatoria predoctoral Consejer\u00eda de Educaci\u00f3n, ciencia y Universidades de la Comunidad de Madrid\u201d","doi-asserted-by":"publisher","award":["PI22\/00473"],"award-info":[{"award-number":["PI22\/00473"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"\u201cConvocatoria predoctoral Consejer\u00eda de Educaci\u00f3n, ciencia y Universidades de la Comunidad de Madrid\u201d","doi-asserted-by":"publisher","award":["DTS23\/00037"],"award-info":[{"award-number":["DTS23\/00037"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"\u201cConvocatoria predoctoral Consejer\u00eda de Educaci\u00f3n, ciencia y Universidades de la Comunidad de Madrid\u201d","doi-asserted-by":"publisher","award":["PIPF-2022\/SAL-GL-24790"],"award-info":[{"award-number":["PIPF-2022\/SAL-GL-24790"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERDF Funds (FEDER) from the European Commission: \u201cA way of making Europe\u201d","award":["PI19\/00792"],"award-info":[{"award-number":["PI19\/00792"]}]},{"name":"ERDF Funds (FEDER) from the European Commission: \u201cA way of making Europe\u201d","award":["PI22\/00584"],"award-info":[{"award-number":["PI22\/00584"]}]},{"name":"ERDF Funds (FEDER) from the European Commission: \u201cA way of making Europe\u201d","award":["PI22\/00473"],"award-info":[{"award-number":["PI22\/00473"]}]},{"name":"ERDF Funds (FEDER) from the European Commission: \u201cA way of making Europe\u201d","award":["DTS23\/00037"],"award-info":[{"award-number":["DTS23\/00037"]}]},{"name":"ERDF Funds (FEDER) from the European Commission: \u201cA way of making Europe\u201d","award":["PIPF-2022\/SAL-GL-24790"],"award-info":[{"award-number":["PIPF-2022\/SAL-GL-24790"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Failure of anti-TNF therapy is a real concern in children with inflammatory bowel disease (IBD) owing to the limited therapeutic arsenal. Anti-TNF drugs modulate the immune response, a key driver of chronic inflammation in IBD. Accordingly, we analyzed changes in the frequency of T-lymphocyte and cytokine levels after 6 weeks of treatment to identify potential biomarkers of response to anti-TNF drugs. We recruited 77 patients under 18 years of age diagnosed with IBD and treated with an anti-TNF drug. Using flow cytometry and multiplex ELISA, we analyzed 31 T-lymphocyte populations and four cytokines. We identified changes in 10 populations of T lymphocytes after 6 weeks of treatment. Na\u00efve Tregs were associated with a primary response to anti-TNF drugs, while activated Tregs were associated with long-term response. Serum INF-\u03b3 levels were decreased after anti-TNF treatment in children with Crohn\u2019s disease (CD), but not in those with ulcerative colitis (UC). The memory CD8+ Type 2 Cytotoxic T (Tc2) subset increased in non-responders with CD and the CD4+ memory Th17 cells increased in non-responders with UC. These findings could help us to understand the cellular regulation of anti-TNF therapy, to identify children at a higher risk of treatment failure, and, potentially, to develop more personalized therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms26073323","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:26:31Z","timestamp":1743611191000},"page":"3323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-1709","authenticated-orcid":false,"given":"Paula","family":"Zapata-Cobo","sequence":"first","affiliation":[{"name":"Servicio de Farmacia, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Salvador-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Servicio de Farmacia, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-3628","authenticated-orcid":false,"given":"Sergio","family":"Gil-Manso","sequence":"additional","affiliation":[{"name":"Laboratory of Immuno-Regulation, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Velasco","family":"Rodr\u00edguez-Belv\u00eds","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Gastroenterolog\u00eda y Nutrici\u00f3n Pedi\u00e1trica, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-9311","authenticated-orcid":false,"given":"Laura M.","family":"Palomino","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Gastroenterolog\u00eda y Nutrici\u00f3n Pedi\u00e1trica, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-1821","authenticated-orcid":false,"given":"Ana","family":"Moreno-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Complejo Hospitalario Universitario A Coru\u00f1a, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-848X","authenticated-orcid":false,"given":"Bego\u00f1a","family":"P\u00e9rez-Moneo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Garc\u00eda-Romero","sequence":"additional","affiliation":[{"name":"Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-3966","authenticated-orcid":false,"given":"Mar\u00eda J.","family":"Fobelo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de Valme, Universidad de Sevilla, 41014 Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-1868","authenticated-orcid":false,"given":"Diana","family":"Garc\u00eda-Tirado","sequence":"additional","affiliation":[{"name":"Hospital Universitario Parc Taul\u00ed, 08208 Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n Infantil, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28009 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Pujol-Muncunill","sequence":"additional","affiliation":[{"name":"Servicio de Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n Pedi\u00e1trica, Hospital Sant Joan de D\u00e9u, 08950 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-1474","authenticated-orcid":false,"given":"Oscar","family":"Segarra","sequence":"additional","affiliation":[{"name":"Hospital Vall d\u2019Hebr\u00f3n, 08035 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Montraveta","sequence":"additional","affiliation":[{"name":"Hospital Universitario Germans Trias i Pujol, 08916 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Magallares","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3456-9986","authenticated-orcid":false,"given":"Rafael","family":"Correa-Rocha","sequence":"additional","affiliation":[{"name":"Laboratory of Immuno-Regulation, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sanjurjo-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Servicio de Farmacia, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-747X","authenticated-orcid":false,"given":"Marjorie","family":"Pion","sequence":"additional","affiliation":[{"name":"Advanced ImmunoRegulation Group, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-5837","authenticated-orcid":false,"given":"Luis A.","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Farmacia, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, 28007 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Guan, Q. (2019). A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J. Immunol. Res., 2019.","DOI":"10.1155\/2019\/7247238"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2024.01.020","article-title":"Early Life and Childhood Environmental Exposures, More Than Genetic Predisposition, Influence Age of Diagnosis in a Diverse Cohort of 2952 Patients with IBD","volume":"22","author":"Khakoo","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/imr.13302","article-title":"Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity","volume":"322","author":"Hall","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gomez-Bris, R., Saez, A., Herrero-Fernandez, B., Rius, C., Sanchez-Martinez, H., and Gonzalez-Granado, J.M. (2023). CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032696"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lv, J., Ibrahim, Y.S., Yumashev, A., Hjazi, A., Faraz, A., Alnajar, M.J., Qasim, M.T., Ghildiyal, P., Hussein Zwamel, A., and Fakri Mustafa, Y. (2024). A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD. Int. Immunopharmacol., 137.","DOI":"10.1016\/j.intimp.2024.112486"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zhang, S., Zhong, R., Tang, S., Chen, L., and Zhang, H. (2024). Metabolic regulation of the Th17\/Treg balance in inflammatory bowel disease. Pharmacol. Res., 203.","DOI":"10.1016\/j.phrs.2024.107184"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Omenetti, S., and Pizarro, T.T. (2015). The Treg\/Th17 axis: A dynamic balance regulated by the gut microbiome. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00639"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1097\/MIB.0000000000000554","article-title":"Restoration of Foxp3 + Regulatory T-cell Subsets and Foxp3-Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases during Anti-tumor Necrosis Factor Therapy","volume":"21","author":"Li","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ibd.21308","article-title":"Therapy with anti-TNF\u03b1 antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases","volume":"17","author":"Boschetti","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.prp.2007.06.007","article-title":"Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease","volume":"203","author":"Mitomi","year":"2007","journal-title":"Pathol. Res. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/jcag\/gwad016","article-title":"The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-Children and Adolescents with IBD","volume":"6","author":"Carroll","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dulic, S., Toldi, G., Sava, F., Kov\u00e1cs, L., Moln\u00e1r, T., Milassin, \u00c1., Farkas, K., Rutka, M., and Balog, A. (2020). Specific T-Cell Subsets Can Predict the Efficacy of Anti-TNF Treatment in Inflammatory Bowel Diseases. Arch. Immunol. Ther. Exp., 68.","DOI":"10.1007\/s00005-020-00575-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.1999.00024.x","article-title":"Review article: Targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn\u2019s disease--the mechanisms of action of infliximab","volume":"13","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Schnell, A., Aicher, C., Schnegelsberg, P.A., Schwarz, B., Schmidt, H., Allabauer, I., R\u00fcckel, A., Regensburger, A.P., Woelfle, J., and Hoerning, A. (2024). Exhausted Lag-3+ CD4+ T cells are increased in pediatric Inflammatory Bowel Disease. Clin. Exp. Immunol., 219.","DOI":"10.1093\/cei\/uxae066"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Salvador-Mart\u00edn, S., Zapata-Cobo, P., Velasco, M., Palomino, L.M., Clemente, S., Segarra, O., S\u00e1nchez, C., Tol\u00edn, M., Moreno-\u00c1lvarez, A., and Fern\u00e1ndez-Lorenzo, A. (2023). Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021797"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2011.01.015","article-title":"Dual role of anti-TNF therapy: Enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues","volume":"139","author":"Raeli","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Maksimovic, J., Huang, B., De Souza, D.P., Naselli, G., Chen, H., Zhang, L., Weng, K., Liang, H., and Xu, Y. (2018). Cord Blood CD8(+) T Cells Have a Natural Propensity to Express IL-4\u2009in a Fatty Acid Metabolism and Caspase Activation-Dependent Manner. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00879"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2147\/JIR.S268484","article-title":"Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease","volume":"13","author":"Sznurkowska","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shan, J., Shi, R., Hazra, R., and Hu, X. (2024). Regulatory T lymphocytes in traumatic brain injury. Neurochem. Int., 173.","DOI":"10.1016\/j.neuint.2023.105660"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nayer, B., Tan, J.L., Alshoubaki, Y.K., Lu, Y.-Z., Legrand, J.M.D., Lau, S., Hu, N., Park, A.J., Wang, X.-N., and Amann-Zalcenstein, D. (2024). Local administration of regulatory T cells promotes tissue healing. Nat. Commun., 15.","DOI":"10.1038\/s41467-024-51353-2"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Loffredo, L.F., Savage, T.M., Ringham, O.R., and Arpaia, N. (2024). Treg-tissue cell interactions in repair and regeneration. J. Exp. Med., 221.","DOI":"10.1084\/jem.20231244"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","article-title":"Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patient","volume":"19","author":"Ueno","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jacobse, J., Li, J., Rings, E.H.H.M., Samsom, J.N., and Goettel, J.A. (2021). Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.716499"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Duclaux-Loras, R., Boschetti, G., Flourie, B., Roblin, X., Leluduec, J.-B., Paul, S., Almeras, T., Ruel, K., Buisson, A., and Bienvenu, J. (2022). Relationships of circulating CD4+ T cell subsets and cytokines with the risk of relapse in patients with Crohn\u2019s disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.864353"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.4049\/jimmunol.1003251","article-title":"IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer","volume":"186","author":"Kryczek","year":"2011","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Laukova, M., and Glatman Zaretsky, A. (2023). Regulatory T cells as a therapeutic approach for inflammatory bowel disease. Eur. J. Immunol., 53.","DOI":"10.1002\/eji.202250007"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2014","journal-title":"Cytokine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/sji.12081","article-title":"Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis","volume":"78","author":"Strid","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S537","DOI":"10.1093\/ecco-jcc\/jjy222.951","article-title":"Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn\u2019s disease","volume":"13","author":"Verstockt","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Menesy, A., Hammad, M., Aref, S., and Abozeid, F.A.M. (2024). Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03218-7"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn\u2019s disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cui, G., Fan, Q., Li, Z., Goll, R., and Florholmen, J. (2021). Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine, 66.","DOI":"10.1016\/j.ebiom.2021.103329"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2010.12.002","article-title":"Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases","volume":"140","author":"Hovhannisyan","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sandy, N.S., Marega, L.F., Bechara, G.D., Riccetto, A.G.L., Bonfim, C., Vilela, M.M.D.S., Ribeiro, A.F., Servidoni, M.D.F., and Lomazi, E.A. (2021). Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency. Rev. Paul. Pediatr., 40.","DOI":"10.1590\/1984-0462\/2022\/40\/2020434"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2017.12.029","article-title":"Genetic profile of patients with early onset inflammatory bowel disease","volume":"645","author":"Girardelli","year":"2018","journal-title":"Gene"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"El-Hussuna, A., Varghese, C., Bhat, V., and Qvist, N. (2022). Inflammatory Response in Patients with Crohn\u2019s Disease Compared with Ulcerative Colitis: Secondary Results of a Prospective Pilot Study. Crohn\u2019s Colitis 360, 4.","DOI":"10.1093\/crocol\/otac047"},{"key":"ref_43","first-page":"1371","article-title":"Cytokine profile in children with inflammatory bowel disease","volume":"79","author":"Toptygina","year":"2014","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cgh.2020.03.066","article-title":"Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients with Inflammatory Bowel Diseases to Infliximab","volume":"19","author":"Jessen","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Salvador-Mart\u00edn, S., L\u00f3pez-Cauce, B., Nu\u00f1ez, O., Laserna-Mendieta, E.J., Garc\u00eda, M.I., Lobato, E., Abarca-Zabal\u00eda, J., Sanjurjo-Saez, M., Lucendo, A.J., and Mar\u00edn-Jim\u00e9nez, I. (2019). Genetic predictors of long-term response and trough levels of infliximab in crohn\u2019s disease. Pharmacol. Res., 149.","DOI":"10.1016\/j.phrs.2019.104478"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:08:58Z","timestamp":1760029738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["ijms26073323"],"URL":"https:\/\/doi.org\/10.3390\/ijms26073323","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]}}}